Skip to content

The effect of probiotic administration to mothers with low birth weight neonates

The effect of probiotic administration to mothers with low birth weight neonates on some of the neonatal and maternal outcomes

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100414003706N42
Enrollment
122
Registered
2022-11-22
Start date
2022-12-22
Completion date
Unknown
Last updated
2024-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Hyperbilirubinemia (Jaundice). Condition 2: Postpartum depression. Condition 3: Mastitis. Neonatal jaundice, unspecified Other depressive episodes Nonpurulent mastitis associated with the puerperium

Interventions

Intervention 1: Intervention group: capsules of the probiotic supplement containing CFU/g 3×109 Lacticaseibacillus paracasei subsp. Paracasei and Bifidobacterium lactis (animals) will be given once a

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Neonatal birth weight of 1000 to 2000 g Delivery in the past 48 h Hospitalization of the infant for at least 7 days after the start of the intervention Possibility of the mother to attend the hospital where the baby is admitted, at least once a week Desire and ability to breastfeed her baby

Exclusion criteria

Exclusion criteria: Triplets or more Bad condition of the infant diagnosed by a neonatologist contraindications for feeding the infant with breast milk Existence of obvious anomalies in the neonate Regular use of probiotics (in any form) by the mother History of sensitivity to probiotics in the mother Immunodeficiency in the mother

Design outcomes

Primary

MeasureTime frame
Total serum bilirubin level in newborn. Timepoint: The fourth and seventh days of intervention. Method of measurement: laboratory assessment.;Postpartum depression. Timepoint: Baseline, 40-45 days after birth. Method of measurement: The Edinburgh Postpartum Depression Scale.

Secondary

MeasureTime frame
Infant weight gain during 40-45 days. Timepoint: At baseline, 7th day of the intervention, discharge day, and 40 to 45 days after birth. Method of measurement: Using a digital scale.;Total duration of phototherapy (hours). Timepoint: During neonatal period. Method of measurement: Daily assessment of infant medical record.;Duration of infant hospitalization. Timepoint: Until discharge from the hospital (if discharged earlier than 40 - 45 days, assessment after 40 -45 days for re-admission to hospital). Method of measurement: Assessment of infant medical record and contact with the mother after 40 - 45 days in case of early discharge.;The composite variable of occurrence of serious neonatal problems (including bronchopulmonary dysplasia, sepsis, necrotizing enterocolitis, or retinopathy of prematurity). Timepoint: 40- 45 days of infancy. Method of measurement: Diagnosed by a neonatologist and an ophthalmologist based on clinical and para-clinical assessments (Retinopathy of prematurity will be assessed by an ophthalmologist after 28 days of infancy) which is recorded in the medical records.;Occurrence of mastitis in the mother. Timepoint: During 40 -45 days of childbirth. Method of measurement: Using the Mastitis scale.;Postpartum anxiety. Timepoint: 40-45 days after birth. Method of measurement: Specific Postpartum Anxiety Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Alikamali

Tabriz University of Medical Sciences

m_kamali1984@yahoo.com+98 42 3342 3494

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 5, 2026